NCT05117450View on ClinicalTrials.gov

Comparison of HYDROLINK™ and HeprAN™ mEmbranes in a Per Dialytic Heparin Weaning Strategy in Chronic Hemodialysis Patients

NARecruitingINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

November 17, 2021

Primary Completion Date

November 17, 2025

Study Completion Date

December 17, 2025

Conditions
Renal Insufficiency
Interventions
DEVICE

Decrease per-dialytic heparin therapy

Decrease per-dialytic heparin therapy with the HYDROLINK membrane (dialyzer NV-21U, surface 2.1m², Toray industry, Tokyo, Japan) and with the HeprAN membrane (dialyzer Evodial 2.2, surface 2.15 m2, Hospal SAS, Meyzieu, France)

Trial Locations (1)

51092

RECRUITING

Chu Reims, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER